NCT06642129

Brief Summary

Target population: patients 18 years of age or older who require surgical treatment with lumboperitoneal shunt surgery for traffic hydrocephalus Estimated sample size: 30 cases. Study design: this study is a multicenter prospective observational study, with lumbar puncture pressure measurement before and during surgery, and shunt valve setting pressure set according to the requirements of clinical practice in the hospital where it is performed, and the collection of relevant data, including preoperative lumbar puncture pressure, intraoperative lumbar puncture pressure after anesthesia, shunt valve initial pressure, shunt valve pressure at 6 months pressure, length of the intravertebral shunt, and length of the intraperitoneal shunt. Complications, shunt effects, and the number of shunt valve adjustments during the 6-month period were also observed and recorded.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jun 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2024

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

September 15, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

October 15, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2025

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

October 15, 2024

Status Verified

September 1, 2024

Enrollment Period

1 year

First QC Date

September 15, 2024

Last Update Submit

October 11, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • primary outcome

    1. Measurement of preoperative bedside lumbar puncture pressure(cmH2O); 2. Measurement of lumbar puncture pressure after anesthesia during lumboperitoneal shunt surgery(cmH2O) ; 3. Initial setting of shunt valve; 4. Setting of shunt valve at 6 months after lumboperitoneal shunt surgery

    preoperation to 6 months after surgery

Secondary Outcomes (1)

  • secondary outcome

    preoperation to 6 months after surgery

Study Arms (1)

Oberservation Group

Patient requiring surgical treatment with lumboperitoneal shunt for communicating hydrocephalus

Procedure: surgery (any volume) and / or pharmaceuticals treatment initiated or planned or only dynamic observation, in accordance with current clinical guidelines

Interventions

Lumboperitoneal shunt (LPS) involves connecting the subarachnoid space of the lumbar spine to the peritoneal cavity through a pressure-adjustable unidirectional valve to shunt the appropriate amount of cerebrospinal fluid from the ventricles to the peritoneal cavity via the spinal canal, where it is absorbed through the peritoneum, to alleviate the increased intracranial pressure caused by the communicating hydrocephalus and the corresponding clinical symptoms.

Oberservation Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients 18 years of age and older who require surgical treatment with lumboperitoneal shunt for communicating hydrocephalus

You may qualify if:

  • Age of 18 years or older;
  • Confirmed diagnosis of communicating hydrocephalus;
  • Signed informed consent for surgery and informed consent for research.

You may not qualify if:

  • Pregnant women;
  • Inappropriate for lumboperitoneal shunt surgery despite the diagnosis of communicating hydrocephalus.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Neurosurgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University

Shanghai, Shanghai Municipality, 200127, China

RECRUITING

MeSH Terms

Conditions

Hydrocephalus

Interventions

Surgical Procedures, Operative

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System Diseases

Central Study Contacts

Junfeng Feng Chief Director, MD,PhD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief Director of Brain Injury Center

Study Record Dates

First Submitted

September 15, 2024

First Posted

October 15, 2024

Study Start

June 1, 2024

Primary Completion

June 1, 2025

Study Completion

December 31, 2025

Last Updated

October 15, 2024

Record last verified: 2024-09

Locations